McKesson Gross Profit 2010-2024 | MCK
McKesson annual/quarterly gross profit history and growth rate from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- McKesson gross profit for the quarter ending March 31, 2024 was $3.585B, a 16.93% increase year-over-year.
- McKesson gross profit for the twelve months ending March 31, 2024 was $12.828B, a 3.8% increase year-over-year.
- McKesson annual gross profit for 2024 was $12.828B, a 3.8% increase from 2023.
- McKesson annual gross profit for 2023 was $12.358B, a 5.88% decline from 2022.
- McKesson annual gross profit for 2022 was $13.13B, a 8.08% increase from 2021.
McKesson Annual Gross Profit
(Millions of US $) |
| 2024 |
$12,828 |
| 2023 |
$12,358 |
| 2022 |
$13,130 |
| 2021 |
$12,148 |
| 2020 |
$12,023 |
| 2019 |
$11,754 |
| 2018 |
$11,184 |
| 2017 |
$11,271 |
| 2016 |
$11,416 |
| 2015 |
$11,411 |
| 2014 |
$8,352 |
| 2013 |
$6,881 |
| 2012 |
$6,402 |
| 2011 |
$5,970 |
| 2010 |
$5,676 |
| 2009 |
$5,378 |
McKesson Quarterly Gross Profit
(Millions of US $) |
| 2024-03-31 |
$3,585 |
| 2023-12-31 |
$3,152 |
| 2023-09-30 |
$3,069 |
| 2023-06-30 |
$3,022 |
| 2023-03-31 |
$3,066 |
| 2022-12-31 |
$3,174 |
| 2022-09-30 |
$3,095 |
| 2022-06-30 |
$3,023 |
| 2022-03-31 |
$3,318 |
| 2021-12-31 |
$3,428 |
| 2021-09-30 |
$3,352 |
| 2021-06-30 |
$3,032 |
| 2021-03-31 |
$3,297 |
| 2020-12-31 |
$3,151 |
| 2020-09-30 |
$3,000 |
| 2020-06-30 |
$2,700 |
| 2020-03-31 |
$3,336 |
| 2019-12-31 |
$3,033 |
| 2019-09-30 |
$2,867 |
| 2019-06-30 |
$2,787 |
| 2019-03-31 |
$3,201 |
| 2018-12-31 |
$2,970 |
| 2018-09-30 |
$2,804 |
| 2018-06-30 |
$2,779 |
| 2018-03-31 |
$3,075 |
| 2017-12-31 |
$2,715 |
| 2017-09-30 |
$2,834 |
| 2017-06-30 |
$2,560 |
| 2017-03-31 |
$2,796 |
| 2016-12-31 |
$2,812 |
| 2016-09-30 |
$2,756 |
| 2016-06-30 |
$2,907 |
| 2016-03-31 |
$2,852 |
| 2015-12-31 |
$2,872 |
| 2015-09-30 |
$2,844 |
| 2015-06-30 |
$2,848 |
| 2015-03-31 |
$2,917 |
| 2014-12-31 |
$2,898 |
| 2014-09-30 |
$2,864 |
| 2014-06-30 |
$2,732 |
| 2014-03-31 |
$2,551 |
| 2013-12-31 |
$1,850 |
| 2013-09-30 |
$2,021 |
| 2013-06-30 |
$1,930 |
| 2013-03-31 |
$1,992 |
| 2012-12-31 |
$1,645 |
| 2012-09-30 |
$1,683 |
| 2012-06-30 |
$1,561 |
| 2012-03-31 |
$1,680 |
| 2011-12-31 |
$1,566 |
| 2011-09-30 |
$1,647 |
| 2011-06-30 |
$1,509 |
| 2011-03-31 |
$1,751 |
| 2010-12-31 |
$1,461 |
| 2010-09-30 |
$1,366 |
| 2010-06-30 |
$1,392 |
| 2010-03-31 |
$1,583 |
| 2009-12-31 |
$1,455 |
| 2009-09-30 |
$1,335 |
| 2009-06-30 |
$1,303 |
| 2009-03-31 |
$1,465 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$77.407B |
$308.951B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
